Navigation Links
Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
Date:2/13/2013

ociated with loss of consciousness or seizure. Fall-related injuries were more severe in XTANDI patients and included non-pathologic fractures, joint injuries, and hematomas. Grade 1 or 2 hallucinations occurred in 1.6% of XTANDI patients and 0.3% on placebo, with the majority on opioid-containing medications at the time of the event.

Drug Interactions- Effect of Other Drugs on XTANDI: Administration of strong CYP2C8 inhibitors can increase the plasma exposure to XTANDI. Co-administration of XTANDI with strong CYP2C8 inhibitors should be avoided if possible. If co-administration of XTANDI cannot be avoided, reduce the dose of XTANDI. Co-administration of XTANDI with strong or moderate CYP3A4 and CYP2C8 inducers can alter the plasma exposure of XTANDI and should be avoided if possible.

Effect of XTANDI on Other Drugs: XTANDI is a strong CYP3A4 inducer and a moderate CYP2C9 and CYP2C19 inducer in humans. Avoid CYP3A4, CYP2C9 and CYP2C19 substrates with a narrow therapeutic index, as XTANDI may decrease the plasma exposures of these drugs. If XTANDI is co-administered with warfarin (CYP2C9 substrate), conduct additional INR monitoring.

For Full Prescribing Information, please visit www.XtandiHCP.com.

About Tivozanib

Tivozanib is a potent, selective and long half-life inhibitor of all three vascular endothelial growth factor (VEGF) receptors that is designed to optimize VEGF blockade while minimizing off-target toxicities. Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor for which positive results from a Phase 3 clinical study in advanced RCC have been reported, and is being evaluated in other tumors.


'/>"/>
SOURCE Astellas Pharma US, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
2. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
3. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
4. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
5. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
6. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
7. CTIA-The Wireless Association Highlights Connected Health Benefits and Potential
8. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
9. Philips Highlights Future Innovations at RSNA 2012 Transformation Lab
10. Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
11. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Levi & Korsinsky is investigating the Board of ... BIIB) for possible violations of federal securities laws. The ... and/or directors have violated Sections 10(b) and 20(a) of ... 24, 2015, prior to the opening of the market, ... other things, the Company lowered its prior revenue guidance ...
(Date:8/4/2015)... -- The Pittsburgh Life Sciences Greenhouse (PLSG), the region,s only ... of its portfolio companies, Medrobotics Corporation, has received FDA ... System in the U.S.  "I couldn,t ... John W. Manzetti , president and CEO of ... spinning out of The Robotics Institute at Carnegie Mellon ...
(Date:8/4/2015)... Aug. 4, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August ... Parker Meridien in New York . ... www.meipharma.com . A replay will be available approximately one ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2
... NEW YORK, Feb. 16, 2012 Delcath Systems, Inc. (NASDAQ: ... entered into an initial launch and training agreement for the ... Center Schleswig-Holstein (Kiel Campus), one of the largest European centers ... to commercially utilize the CHEMOSAT system to treat patients. Under ...
... Inc., a leading provider of revenue and payment ... announced a clinical services agreement with Informatics Corporation ... and results as well as EHR capabilities. ... developed by Vanderbilt Medical Center in Nashville, Tennessee, ...
Cached Medicine Technology:Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 2Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 3Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 4Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 2Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 3Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 4Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 5
(Date:8/5/2015)... , ... August 05, 2015 , ... HealthyYOU Vending says ... campaign by the City & County of San Francisco are representative of initiatives ... M. Lee recently approved a measure from the City and County of San Francisco ...
(Date:8/5/2015)... ... August 05, 2015 , ... The President ... honored as one of this year’s 50 Most Influential Women in Arizona by ... business. Carol May’s long-standing dedication to the well-being of consumers through Wisdom Natural ...
(Date:8/4/2015)... ... August 05, 2015 , ... ... Stevens as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting more than ...
(Date:8/4/2015)... ... August 05, 2015 , ... The Journal of Pain Research has ... corresponding author Professor Akiko Okifuji says “Both obesity and chronic pain are serious public ... say that one causes the other. Rather, there appear to be multiple factors that ...
(Date:8/4/2015)... ... August 04, 2015 , ... assistPoint Partners, LLC ... consolidate oncology patient assistance programs. Through a secure web portal, assistPoint connects Life ... an enterprise level, cloud-based application and workflow solution. This provides cancer center patient ...
Breaking Medicine News(10 mins):Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 2Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 3Health News:Carol May Named One of the Most Influential Woman in Arizona 2Health News:Carol May Named One of the Most Influential Woman in Arizona 3Health News:Carol May Named One of the Most Influential Woman in Arizona 4Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:assistPoint.com Web Site Launched 2
... puzzling over the case of 44-year-old civil servant who has ... tiny brain . ,In a case history published ... the Hopital de la Timone in Marseille say the father-of-two ... left leg. ,Scans by computed tomography (CT) and ...
... an issue for every country and ultimately, for every food ... incidents that occurred in the last 12 months, two agencies ... when dealing with traders and producers that affect the supply ... Organization (FAO) and the World Health Organization (WHO) cited the ...
... star this week for allegedly organizing illegal dog fights has ... attracting an increasingly wide following. ,The blood ... illegal in all 50 states, but can be found across ... very prevalent in the South now it's all over, in ...
... the University Clinic of the University of Navarra have ... adult stem cell growth for its capacity to ... ,Ana Fernandez Hortelano, ophthalmologist at the hospital, applied ... cornea in 70 rabbits for the purpose of regaining ...
... containing HIV but must remove the stigma associated with the ... control, international research chiefs say. ,Speaking ahead ... next week, America's top expert Anthony Fauci and his Australian ... risk in Asia. ,Fauci said predictions HIV would ...
... drug proven effective in preventing prostate cancer, just because it ... now put their fears to rest, thanks to a new ... Oncology Group, found that though the drug does cause a ... of time. ,As a part of their study, ...
Cached Medicine News:Health News:Gaps In Food Safety Systems Must Be Plugged :UN 2Health News:Dog Fighting in the US: Bloody, Illegal and Booming 2Health News:Asia Must Overcome HIV Stigma, Say Research Chiefs 2Health News:Asia Must Overcome HIV Stigma, Say Research Chiefs 3Health News:Mens Sexual Prowess Not Affected by Prostate Cancer Drug 2
The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...
... StelKast's Proven™ knee system ... solution based on a clinically ... posterior stabilized and anatomically correct ... instrument standardization and ease of ...
... Oxinium (oxidized zirconium) isn't a new implant. ... Smith & Nephew. Wear debris can be ... almost nil, addressing the needs of the ... are all improved. Initially, Oxinium is available ...
The RT-PLUS Solution is an axially supported rotation knee prosthesis for cemented implantation. The implant is available in three sizes, each of which can be combined with the next size up or down....
Medicine Products: